GALECTIN THERAPEUTICS INC
GALT·363225202·US·Common Stock·Healthcare - Biotechnology-Activist
GALT (GALECTIN THERAPEUTICS INC) is held by 66 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($13.9M), VANGUARD CAPITAL MANAGEMENT LLC ($10.1M), GEODE CAPITAL MANAGEMENT, LLC ($6.1M). Net institutional sentiment: Mixed.
66
Holders
(6 Elite)
$66.4M
Total Value
59% (70)
Consensus
41 buying - 29 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Aug 4, 2026 · Activists Aug 4, 2026 · Congress none
ActivistRERichard E. Uihlein49.3%Aug 4, 2026
InsiderUEUihlein Richard EExercise 2.6M shJul 31, 2026
InsiderUEUihlein Richard EExercise 31.8M shJul 31, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 78
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer